Colorectal Cancer Cases Tripled in Teens
May 13th, 2024
The overall shift of these cancers being seen in younger people and evidence of “a trend that did not stop with the 20-year-olds,”Dr. John L. Marshall says.…
This program honors and celebrates the accomplishments of leading researchers and educators whose discoveries have propelled the field and set the groundwork for future advancements.
Learn about new Ruesch faculty led GI cancer research, advocacy events, and patient community-building initiatives.
The summit provides information and tools to manage cancer care and the opportunity to interact in small group settings with clinicians
One of the most meaningful gifts you can give cancer patients and their families is hope.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Colorectal Cancer Cases Tripled in Teens
May 13th, 2024
The overall shift of these cancers being seen in younger people and evidence of “a trend that did not stop with the 20-year-olds,”Dr. John L. Marshall says.…
National Cancer Institute Renews Georgetown Lombardi Top Designation
May 2nd, 2024
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care…
Dr. John Marshall Inducted into Giants of Cancer Care
May 2nd, 2024
This program honors and celebrates the accomplishments of leading researchers and educators whose discoveries have propelled the field and set the groundwork for future advancements.…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.